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GABAergic and Glutamatergic Identities
of Developing Midbrain Pitx2 Neurons
M.R. Waite,1 J.M. Skidmore,2 A.C. Billi,3 J.F. Martin,4 and D.M. Martin2,3*
Pitx2, a paired-like homeodomain transcription factor, is expressed in post-mitotic neurons within highly
restricted domains of the embryonic mouse brain. Previous reports identified critical roles for PITX2 in
histogenesis of the hypothalamus and midbrain, but the cellular identities of PITX2-positive neurons in
these regions were not fully explored. This study characterizes Pitx2 expression with respect to midbrain
transcription factor and neurotransmitter phenotypes in mid-to-late mouse gestation. In the dorsal mid-
brain, we identified Pitx2-positive neurons in the stratum griseum intermedium (SGI) as GABAergic and
observed a requirement for PITX2 in GABAergic differentiation. We also identified two Pitx2-positive neu-
ronal populations in the ventral midbrain, the red nucleus, and a ventromedial population, both of which
contain glutamatergic precursors. Our data suggest that PITX2 is present in regionally restricted subpo-
pulations of midbrain neurons and may have unique functions that promote GABAergic and glutamater-
gic differentiation. Developmental Dynamics 240:333–346, 2011. VC 2011 Wiley-Liss, Inc.
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INTRODUCTION
The midbrain is an important relay
center that receives and processes
sensory inputs and transmits signals
to motor outputs in the hindbrain and
spinal cord (Wickelgren, 1971; Mere-
dith and Stein, 1986). The dorsal and
ventral midbrain are divided by ana-
tomic location and have distinct func-
tional roles and developmental pro-
grams. The developing midbrain can
be subdivided into three medio-lateral
zones: a deeply localized ventricular
zone, an intermediate zone, and a su-
perficial mantle zone. Along the
dorso-ventral axis, the midbrain is
comprised of seven domains (m1–m7),
each characterized by unique combi-
nations of transcription factors, sig-
naling molecules, and neurotransmit-
ter expression (Nakatani et al., 2007;
Kala et al., 2009). The dorsal domains
(m1–m3) make up the superior colli-
culus and are organized into layers,
whereas the ventral domains (m4–
m7) are organized into distinct nuclei.
The superior colliculus receives
multisensory inputs from the retina,
cortex, and spinothalamic pathway
(Mehler et al., 1960; Garey et al.,
1968; Valverde, 1973). These inputs
are important for movement of the
head and limbs in response to stimuli,
attention, and mediating saccades
(Sparks and Mays, 1990; Kustov and
Robinson, 1996; Lunenburger et al.,
2001). Dorsal midbrain layers develop
in an inside-out manner, whereby
early born neurons migrate radially
to reach a predestined layer, then
migrate tangentially to their final
rostro-caudal destinations (Edwards
et al., 1986; Tan et al., 2002). In this
fashion, older neurons occupy deeper
layers and younger neurons are
located more superficially (Altman
and Bayer, 1981). Neurogenesis in the
dorsal mouse midbrain occurs
between E11.5–E14.5 (Edwards et al.,
1986). Early born neurons migrate
and differentiate such that by E18.5,
all seven layers of the superior colli-
culus (stratum zonale [SZ], stratum
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opticum [SO], stratum griseum inter-
medium [SGI], stratum album inter-
medium [SAI], stratum griseum pro-
fundum [SGP], and stratum album
profundum [SAP]) are established
(Altman and Bayer, 1981; Edwards
et al., 1986). Between E18.5 and P6,
collicular layers expand radially,
become better defined, and undergo
refinement of fiber bundles (Edwards
et al., 1986).
The ventral midbrain is important
for control of limb movement and loco-
motor coordination, and for mediating
reward and stress responses (Le Moal
and Simon, 1991; Feenstra et al., 1992;
Sinkjaer et al., 1995). The ventral mid-
brain consists of domains m4–m7 and,
unlike the layered dorsal midbrain, is
comprised of distinct nuclei (red nu-
cleus, oculomotor nucleus, Edinger-
Westphal nucleus, reticular formation,
ventral tegmental area, and substantia
nigra) that are organized in a stereo-
typic pattern (Hasan et al., 2010). Dur-
ing development, the ventral midbrain
is divided into five morphogenetic arcs,
Fig. 1.
Fig. 1. PITX2 identifies GABAergic interneurons
in an intermediate layer of the dorsal midbrain. A:
Cartoon showing sagittal view of an embryonic
mouse brain with midbrain highlighted in pink and
a dotted line indicating the location of coronal
sections shown in C–T. B: Cartoon of a coronal
midbrain section highlighting the superior collicu-
lus (SC), aqueduct (AQ), alar-basal boundary, and
the ventricular (VZ), intermediate (IZ), and mantle
zones (MZ). C–H: E14.5 and P8 midbrains proc-
essed for immunofluorescence for PITX2 (red)
and GABA (green). E0, H0: Enlarged boxes in E
and H. At E14.5, PITX2-positive and GABA-posi-
tive cells are located in the intermediate and man-
tle regions of the superior colliculus, where most
PITX2-positive cells are also GABA-positive (E0).
White arrow in E0 indicates co-localization of
PITX2 and GABA. Open arrow indicates a GABA-
positive, PITX2-negative neuron. F–H0: At P8,
PITX2-positive cells occupy an intermediate
GABAergic layer of cells where GABA-positive
cytoplasm surrounds PITX2-positive nuclei. I–N:
E14.5 and P8 midbrains processed for immuno-
fluorescence for LHX1/5 and GABA. K0, N0:
Enlarged boxes in K and N. At E14.5, LHX1/5-
positive cells are distributed throughout the supe-
rior colliculus, whereas GABA-positive cells reside
in the intermediate and mantle zones. At P8,
some LHX1/5-positive cells are GABA-positive
(white arrow in K0). The open arrow in K0 indicates
a GABA-positive, LHX1/5-negative neuron. O–Q0:
At P8, PITX2-positive neurons are localized su-
perficial to the LHX1/5-positive population. R–T:
Adjacent sections from P8 brains processed for
acetylcholinesterase (AChE) staining and Pitx2 in
situ hybridization shows Pitx2 mRNA and AChE
strongly expressed in an intermediate superior
colliculus layer, the stratum griseum intermedium
(SGI). Dotted lines indicate the outline of the
AChE-positive layer. Scale bar in C ¼ 100 mm
and applies to C–E and I–K; in F ¼ 100 mm and
applies to F–H and L–Q; in R ¼ 250 mm and
applies to R–T. L–N0 were imaged using confocal
microscopy. MZ, mantle zone; IZ, intermediate
zone; SGS, stratum griseum superficiale; SO,
stratum opticum; SGI, stratum griseum interme-
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each distinguishable by a unique pat-
tern of transcription factor expression
(Agarwala and Ragsdale, 2002; Sand-
ers et al., 2002). Cells in these arcs are
postulated to undergo nucleogenesis,
during which cells receive specific sig-
nals to differentiate and migrate to
form distinct anatomic nuclei based on
their location within each arc (Agar-
wala and Ragsdale, 2002). Nucleogene-
sis in the ventral midbrain requires
precise temporal and spatial control of
transcription factor expression (Bayly
et al., 2007; Andersson et al., 2008),
although the unique contributions of
these transcription factors have not
been fully characterized.
Previous studies showed that the
transcription factor PITX2 is required
for proper midbrain development (Mar-
tin et al., 2004). Pitx2 is expressed in
both dorsal and ventral midbrain sub-
populations and is required for proper
migration of collicular neurons into the
intermediate zone and mantle zone
(Martin et al., 2004). In the superior
colliculus, a subpopulation of post-mi-
totic PITX2-positive neurons was iden-
tified as GABAergic (Martin et al.,
2002). Ventral PITX2-positive popula-
tions have not been characterized.
Other researchers have begun to map
midbrain transcription factors by do-
main and factor co-expression (Naka-
tani et al., 2007; Kala et al., 2009), but
PITX2 has not been incorporated into
these maps. Here, we characterized
dorsal and ventral midbrain Pitx2-posi-
tive cells for their neurotransmitter
identities, localization within the neu-
roepithelium, and early co-expression
with other transcription factors and
signaling molecules. We also placed
PITX2 within the emerging paradigm
of m1–m7 dorso-ventral midbrain
domains. Our results suggest that
PITX2 may have unique roles in the
development of midbrain GABAergic
versus glutamatergic neurons.
RESULTS
PITX2 Is Expressed in
GABAergic Neurons of the
Intermediate Superior
Colliculus
To determine the identity of PITX2-
positive neurons in the dorsal mid-
brain, we used double immunofluores-
cence with antibodies against PITX2
Fig. 2. Collicular glutamatergic neurons are BRN3A-positive and PITX2-negative. Coronal sections of
E14.5 and P8 midbrains were processed for immunofluorescence for PITX2 and VGLUT2 (A–F). Boxes
in C and F are enlarged in C0 and F0. Dotted lines indicate the midbrain pial surface. A–C0: At E14.5,
VGLUT2 is absent from the dorsal midbrain. D–F0: At P8, PITX2-positive cells are located in the SGI and
VGLUT2-positive neurons occupy the intermediate and deep layers of the superior colliculus; however,
VGLUT2-positive staining does not circumscribe the PITX2-positive nuclei. G–L0: Coronal sections of
E14.5 and P8 midbrains processed for immunofluorescence for BRN3A and VGLUT2. Boxes in I and L
are enlarged in I0 and L0. At E14.5, BRN3A-positive cells are located in the deep and intermediate supe-
rior colliculus, and VGLUT2 is absent. J–L0: At P8, VGLUT2 circumscribes collicular BRN3A-positive
nuclei. M–R: Coronal sections from E16.5 (M–O) and E18.5 (P–R) embryos labeled with antibodies
against PITX2 and BRN3A show that PITX2 is present in an intermediate layer positioned between two
BRN3A-positive layers. P–R: At E18.5, PITX2 and BRN3A continue to be localized in separate tectal
layers and the PITX2-positive layer appears more compact. Dotted lines indicate the outline of the
PITX2-positive collicular layer. Scale bar in A ¼ 100 mm and applies to A–C and G-1; in D ¼ 100 mm
and applies to D–F and J–L; in M¼ 100 mm and applies to M–R. D–F0 and J–L0 were imaged using con-
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and markers of specific neurotrans-
mitters. In the E14.5 superior collicu-
lus, most PITX2-positive cells were
positive for GABA (Fig. 1C–E0). At
postnatal day 8 (P8), all PITX2-posi-
tive neurons in the superior colliculus
had undergone GABAergic differen-
tiation and were surrounded by
GABAergic cytoplasm (Fig. 1F–H0). In
order to determine whether GABAer-
gic neurons could be identified by
LHX1, a transcription factor ex-
pressed during collicular GABAergic
differentiation (Kala et al., 2009), we
analyzed collicular neurons for LHX1/
5 and GABA co-localization. At E14.5,
many intermediate collicular neurons
were positive for both LHX1/5 and
GABA (Fig. 1I–K0). Near the pial sur-
face, the majority of GABA-positive
neurons were LHX1/5-negative. At
P8, densely labeled GABA-positive
neurons continued to express LHX1/5
(Fig. 1L–N0). PITX2-positive cells
were located superficial to LHX1/5-
positive cells (Fig. 1O–Q0), indicating
that PITX2 and LHX1/5 mark differ-
ent GABAergic subpopulations of the
superior colliculus.
GABAergic neurons are abundant
in the midbrain and are especially
prevalent in the superficial layers and
the intermediate layer (SGI) of the
colliculus (Lee et al., 2007). The SGI
receives numerous cholinergic inputs
and can be identified by staining for
the cholinergic enzyme acetylcholin-
esterase (AChE) (McHaffie et al.,
1991). To determine whether collicu-
lar PITX2-positive cells are located in
the SGI, we analyzed dorsal mid-
brains for Pitx2 and AChE expres-
sion. At P8, the SGS and SGI were
easily identified by strong AChE
staining (Fig. 1R) and Pitx2-express-
ing cells were identified within the in-
termediate AChE positive layer (Fig.
1S,T), indicating that collicular Pitx2-
positive neurons are located in the
SGI.
Because the SGI layer is rich in glu-
tamatergic afferents, we analyzed the
expression of PITX2 and vesicular
glutamate transporter 2 (VGLUT2), a
membrane transport protein respon-
sible for glutamate uptake into
vesicles. At E14.5, VGLUT2 was
absent in the dorsal midbrain (Fig.
2A–C0). At P8, VGLUT2 was present
throughout the intermediate and
deep layers of the superior colliculus
and was not co-localized at the cellu-
lar level with PITX2 (Fig. 2D–F0).
This is consistent with known gluta-
matergic afferents projecting to the
SGI including cortico-collicular, ret-
ino-collicular, and colliculo-collicular
pathways (Woo et al., 1985; Mize and
Butler, 1996; Olivier et al., 2000). To
further characterize glutamatergic
neurons in the colliculus, we analyzed
expression of the transcription factor
BRN3A, which marks the nuclei of
glutamatergic precursor neurons
(Fedtsova and Turner, 1995; Nakatani
et al., 2007). BRN3A-positive cells
were distributed throughout the
E14.5 intermediate and medial supe-
rior colliculus (Fig. 2G–I0). At P8,
BRN3A-positive nuclei were tightly
associated with VGLUT2-positive
label throughout the colliculus (Fig.
2J–L0), suggesting these BRN3A-posi-
tive cells are glutamatergic. We also
examined PITX2 and BRN3A expres-
sion at E16.5 and E18.5. At E16.5, the
PITX2-positive cell layer was tightly
situated between two BRN3A layers
with minimal intermingling among
the cells (Fig. 2M–O), suggesting that
BRN3A-positive cells are situated in
the SAI and a sublayer within the
SGI or SO. At E18.5, the BRN3A and
PITX2-positive layers were more
defined and no intermingling among
cells in these layers occurred (Fig.
2P–R). Thus, collicular layers can be





Since Pitx2 is expressed in GABAer-
gic neurons in the dorsal midbrain
during early collicular differentiation,
we reasoned it might be co-expressed
with dorsal GABAergic precursor
markers such as LHX1/5 and GATA2.
GATA2 is a transcription factor
expressed in post-mitotic neurons in
the early stages of GABAergic differ-
entiation and LHX1 is expressed
downstream of GATA2 (Kala et al.,
2009). At E12.5, GATA2-positive cells
occupied the intermediate superior
colliculus, whereas PITX2-positive
neurons were found in the mantle
zone (Fig. 3A). At E14.5, GATA2 was
restricted to cells located superficially
to the ventricular zone and did not
co-localize with PITX2 (Fig. 3B). At
E12.5, LHX1/5-positive cells were
localized to the mantle zone, more
superficially than GATA2, and found
Fig. 3. PITX2-positive cells represent a unique population of GABAergic dorsal midbrain pre-
cursors. Coronal sections of E12.5 and E14.5 midbrains were processed for double immunofluo-
rescence with antibodies against markers of neuronal precursors. At E12.5 and E14.5, PITX2-
positive cells (red) reside in the mantle layer of the superior colliculus. A,B: GATA2-positive cells
are located intermedially at E12.5 and extend throughout the superior colliculus at E14.5, but do
not overlap with PITX2-positive cells. C,D: LHX1/5 is located deep to PITX2 at E12.5 and by
E14.5 LHX1/5-positive cells are found throughout the superior colliculus. At both timepoints,
only a few neurons show co-localization of both markers (insets in C0,D0). White arrows indicate
cells with co-localization. E,F: BRN3A and PITX2 are present in distinct cells at E12.5 and
E14.5. G,H: PAX3-positive cells are found throughout dorsal ventricular and intermediate zones
and are PITX2-negative at E12.5. H: At E14.5, PAX3-positive cells are PITX2-negative and ven-
tricularly restricted. I,J: PAX7-positive cells are broadly distributed throughout the superior colli-
culus and expanded superficially at E14.5 but do not co-localize with PITX2. Dotted lines
indicate the pial surface. Scale bars in A and B ¼ 100 mm and apply to A, C, E, G, I and B, D,
F, H, J, respectively. MZ, mantle zone; IZ, intermediate zone; VZ, ventricular zone.
Fig. 4. PITX2 is required for GABAergic differentiation. Coronal sections of E14.5 Pitx2Cre/þ;NL
and Pitx2Cre/;NL midbrains were processed for double immunofluorescence with antibodies
against bGAL and GABA (A,B). Boxes in A and B are enlarged in A0 and B0. A,A0: PITX2-lineage
cells in the Pitx2Cre/þ;NL embryo are located near the pial surface in a strongly GABAergic layer
and are GABA-positive. B,B0: PITX2-lineage cells in the Pitx2Cre/;NL embryo are medially mislo-
calized and are GABA-negative. C–L: Pitx2Cre/þ;NL and Pitx2Cre/;NL coronal E14.5 midbrain
sections were processed for immunofluorescence with antibodies against PAX3, PAX7, GATA2,
LHX1/5, or BRN3A. C,D: PAX3 is restricted to the ventricular zone in both Pitx2Cre/þ;NL and
Pitx2Cre/;NL embryos. E,F: PAX7-positive cells are distributed throughout the colliculus of both
Pitx2Cre/þ;NL and Pitx2Cre/;NL midbrains. G,H: GATA2 is restricted to deep collicular cells and
loss of PITX2 does not affect GATA2 patterning. I–L: In both Pitx2Cre/þ;NL and Pitx2Cre/;NL mid-
brains, LHX1/5- and BRN3A-positive cells are spread throughout the superior colliculus. A–L
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deeper than PITX2-positive neurons
(Fig. 3C). At E14.5, LHX1/5-positive
cells extended from the ventricular
zone to the sub-pial surface (Fig. 3D).
At both E12.5 and E14.5, only a few
cells were positive for both PITX2 and
LHX1/5 (Fig. 3C0,D0). Thus, PITX2,
GATA2, and LHX1/5 appear to mark
distinct subpopulations of GABAergic
collicular neurons. At E12.5, BRN3A-
positive cells were located adjacent and
deeper than PITX2-positive cells,
whereas at E14.5 BRN3A was
expressed throughout the ventral and
intermediate colliculus (Fig. 3E,F). Col-
licular PITX2-positive cells are thus
negative for BRN3A during early devel-
opment, providing further evidence
against glutamatergic identity of
PITX2-positive cells.
Unlike GATA2, LHX1/5, and
BRN3A, which are required for cell-
type differentiation, PAX3 and PAX7
transcription factors are necessary for
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(Thompson et al., 2004, 2008). Pax3 is
expressed transiently in all early collic-
ular cells and expression disappears by
birth (Thompson et al., 2008). Pax7 is
also expressed in early collicular cells,
but continues to be expressed in the
mature colliculus where it regulates
maintenance of superficial collicular
layers (Thompson et al., 2008). We
found no overlap between PITX2 and
PAX3 or PAX7 at E12.5–E14.5 in the
dorsal midbrain (Fig. 3G–J). Together,
these data indicate that PITX2-positive
neurons represent a subpopulation of
superior colliculus cells with unique
molecular signatures.
PITX2 Is Required for
GABAergic Differentiation,
But Not Early Collicular
Patterning
Previous studies showed that PITX2
is downstream of the transcription
factor GATA2, which is necessary for
collicular GABAergic differentiation
(Kala et al., 2009). Additionally, in
vitro studies suggested that mouse
PITX2 activates the promoter of
Gad1, which encodes the enzyme for
GABA synthesis (Westmoreland
et al., 2001). To determine whether
PITX2 is required for collicular
GABAergic differentiation, we crossed
Pitx2Cre/þ mice to a nuclear LacZ (NL)
reporter strain (Skidmore et al.,
2008). Pitx2Cre/þ;NL mice permanently
express b-galactosidase (bGAL) in the
nuclei of PITX2-lineage neurons (Skid-
more et al., 2008). We compared E14.5
Pitx2Cre/þ;NL and Pitx2Cre/;NL litter-
mate midbrains for GABAergic differ-
entiation of Pitx2-lineage cells. In
Pitx2Cre/þ;NL midbrains, bGAL-posi-
tive cells were positive for GABA and
localized in the mantle zone in a
highly GABAergic layer (Fig. 4A,A0).
In Pitx2Cre/;NL midbrains, bGAL-
positive cells were medially mislocal-
ized in a GABA-poor layer and were
GABA-negative (Fig. 4B,B0). Interest-
ingly, the Pitx2Cre/;NL colliculus also
appeared to have fewer bGAL-positive
cells compared to Pitx2Cre/þ;NL, sug-
gesting there may be reduced neuro-
genesis or increased cell death of this
population. These data suggest that
PITX2 is required for both cellular
migration and GABAergic differentia-
tion in the superior colliculus.
To determine whether PITX2 is also
necessary for early collicular pattern-
ing, we analyzed the expression pat-
terns of early midbrain transcription
factors in PITX2 mutant embryos.
Loss of PITX2 did not disrupt the
pattern of the general collicular pre-
cursor markers PAX3 and PAX7
(Fig. 4C–F; see Supp. Fig. S1, which
is available online). Additionally, the
GABAergic precursor markers
GATA2 and LHX1/5 and the glutama-
tergic precursor marker BRN3A were
correctly localized in Pitx2Cre/;NL
midbrains (Fig. 4G–L). This indicates
that although PITX2 is required for
the GABAergic differentiation of a
subpopulation of collicular neurons, it
is not necessary for general early pat-
terning of the superior colliculus.




To characterize the molecular profiles
of m6 ventromedial and red nucleus
PITX2-positive neurons, we analyzed
early transcription factor co-localiza-
tion with PITX2. At E12.5, many ven-
tromedial PITX2-positive cells were
also positive for FOXA2, LHX1/5, and
BRN3A (Fig. 5A–I). In the m1–m5
domains, LHX1/5-positive neurons
become GABAergic, whereas in the
m6 domain, LHX1/5-positive cells
become glutamatergic (Nakatani
et al., 2007). Thus, PITX2 co-localiza-
tion with LHX1/5 and BRN3A sug-
gests a glutamatergic fate for many
ventromedial m6 PITX2-positive cells.
FOXA2 is present in the m6 and m7
domains, where it inhibits GABAergic
differentiation via regulation of Nkx
family transcription factors and
repression of early factors necessary
for GABAergic fates such as Helt
(Ferri et al., 2007; Lin et al., 2009).
Many ventromedial PITX2-positive
cells were also positive for NKX6.2
(Fig. 5J–L), a transcription factor
necessary for m6 identity (Prakash
et al., 2009). Because all ventromedial
PITX2-positive cells were also
NKX6.2 positive, it is possible that
ventromedial PITX2 marks a previ-
ously uncharacterized NKX6.2 subpo-
pulation (Prakash et al., 2009). At
E12.5, the majority of PITX2-positive
red nucleus cells were also positive
for FOXA2, LHX1/5, and BRN3A (Fig.
5M–U). These results suggest that
PITX2 marks two heterogeneous cell
populations in the ventral midbrain, a
ventromedial one and a more lateral
red nucleus population, both of which
contain glutamatergic precursors that
have distinct molecular signatures.
To further characterize Pitx2
expression in the ventral midbrain,
we co-labeled PITX2-positive cells
with additional ventral midbrain
markers. In the ventral midbrain,
Nkx2.2 is expressed in m5 progenitors
Fig. 5. PITX2 identifies restricted populations of ventromedial midbrain precursors. Immunoflu-
orescence of E12.5 midbrain coronal sections processed with antibodies against PITX2 (red)
and other ventral midbrain markers (green) and imaged with confocal microscopy. A0: Cartoon
showing coronal view of an embryonic mouse midbrain identifying two ventral PITX2-positive
populations. Boxes indicate the location of the ventromedial (VM) and red nucleus PITX2-posi-
tive populations magnified in A–L and M–U, respectively. A–C: FOXA2 marks precursors in the
m6 domain and is co-localized with PITX2 in deep m6. D–I: Most ventromedial PITX2-positive
cells are positive for LHX1/5 and BRN3A, which mark glutamatergic precursors in the m6
domain. J–L: NKX6.2-positive cells in deep m6 are also PITX2-positive. White arrows indicate
transcription factor co-localization with PITX2, whereas open arrows indicate PITX2-positive,
FOXA2, LHX1/5, or BRN3A-negative cells. M–U focus on PITX2-positive cells in the red nucleus.
M–R: PITX2-positive cells in the red nucleus are FOXA2 and LHX1/5-positive. S–U: Most but not
all BRN3A-positive red nucleus cells are PITX2-positive. Scale bar in A applies to A–U and ¼ 25
mm.
Fig. 6. Ventral midbrain domains are delineated by transcription factor patterning. E12.5 coro-
nal sections were processed for immunofluorescence with antibodies against PITX2 (red) and
other ventral midbrain markers (green) and imaged with confocal microscopy. A: NKX6.1 is re-
stricted to m6 progenitors and a PITX2-negative region between deep m6 and the PITX2-posi-
tive red nucleus. B: Ventromedial PITX2-positive cells in m6 reside near GATA2-positive cells in
the m5 domain. C: NKX2.2-positive cells occupy m4 and m5, but not the m6 domain. D: ISL1-
positive oculomotor neurons (OMN) are located superficially to the deep PITX2 population in
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and m4 post-mitotic cells (Nakatani
et al., 2007), whereas NKX6.1 and
NKX6.2 are expressed in m6. Nkx6.1
is expressed in m6 progenitors and in
post-mitotic oculomotor neurons and
is required for proper fate of cells in
the red nucleus and oculomotor nu-
cleus (Prakash et al., 2009). We found
that NKX6.1-positive cells were
located in the m6 ventricular zone
and positioned between the two
PITX2-positive populations, although
no co-localization was observed
between PITX2 and NKX6.1 (Fig.
6A). Nkx2.2 and Gata2 are expressed
in m5 GABAergic progenitors and
precursors, respectively (Nakatani
et al., 2007; Joksimovic et al., 2009;
Kala et al., 2009). Neither NKX2.2
nor GATA2 co-localized with PITX2
(Fig. 6B,C), further suggesting that
ventral midbrain PITX2-positive neu-
rons do not undergo GABAergic dif-
ferentiation. ISLET1 (ISL1) marks
the oculomotor nucleus in m6 and did
not co-localize with PITX2, indicating
that PITX2-positive cells do not con-
tribute to the oculomotor nucleus
(Fig. 6D).
To determine whether PITX2 is nec-















340 WAITE ET AL.
patterning of the ventral midbrain,
we compared gene expression in
E12.5 Pitx2Cre/þ and Pitx2Cre/ litter-
mate midbrains (Fig. 7). Transcrip-
tion factor patterning in the midbrain
was similar in Pitx2Cre/þ and wildtype
embryos (Fig. 5). BRN3A (green) was
dispersed throughout the ventrome-
dial zone and red nucleus in both
Pitx2Cre/þ and Pitx2Cre/ midbrains
(Fig. 7A–J). FOXA2 was present in
the ventricular zone, ventromedial
population, and the red nucleus and
was unchanged in Pitx2Cre/ embryos
(Fig. 7A,B). LHX1/5-positive cells
were distributed throughout the ven-
tromedial population and the red nu-
cleus in both Pitx2Cre/þ and Pitx2Cre/
midbrains (Fig. 7C,D). Loss of PITX2
did not affect the localization of
NKX6.1 cells, which are BRN3A-neg-
ative (Fig. 7E,F). The oculomotor nu-
cleus marker, ISL1, also appeared
normal in Pitx2Cre/ midbrains (Fig.
7G,H). The majority of NKX6.2-posi-
tive cells were negative for BRN3A,
with only a few double-labeled cells
in the intermediate zone of the
ventral midbrain (Fig. 7I,I0); this pat-
tern of expression was unchanged in
Pitx2Cre/ embryos (Fig. 7J,J0). Tran-
scription factor patterns also
appeared unchanged in Pitx2Cre/
mutants in the rostral-caudal plane
(Supp. Fig. S1). Together, these data
indicate that PITX2 is not necessary
for early ventral midbrain patterning.
PITX2 Is Transient in
Glutamatergic Red Nucleus
Neurons
In order to establish whether ventral
PITX2-positive neurons are GABAer-
gic or glutamatergic, we analyzed
E14.5 ventral midbrains for PITX2
and BRN3A, VGLUT2, or GABA. We
found that only a few red nucleus
cells were PITX2-positive at E14.5
(Fig. 8A), in contrast with the E12.5
PITX2-positive red nucleus (Fig. 5).
At E14.5, the few ventral PITX2-posi-
tive cells were also BRN3A-positive,
suggesting that these neurons become
glutamatergic (Fig. 8B–C0). In con-
trast, most GABA immunofluores-
cence was localized to the m5 domain
and was not present in PITX2-posi-
tive cells (Fig. 8D–F0). Although pre-
vious studies suggested the presence
of GABAergic neurons in the red nu-
cleus (Katsumaru et al., 1984; Vuil-
lon-Cacciuttolo et al., 1984), we did
not observe GABA in midbrain red
nucleus neurons during development
(Fig. 8F).
We next asked whether PITX2-line-
age red nucleus neurons are glutama-
tergic by analyzing Pitx2Cre/þ;NL
embryos for bGAL and VGLUT2 immu-
nofluorescence. At E18.5, bGAL-posi-
tive red nucleus neurons were
VGLUT2-positive, suggesting that red
nucleus PITX2-lineage cells are
glutamatergic (Fig. 8G–I0). We also
identified co-localization between
bGAL and BRN3A in the red nucleus of
Pitx2Cre/þ;NL embryos (Fig. 8J–L). This
co-localization with BRN3A further
suggests that red nucleus PITX2-line-
age neurons adopt a glutamatergic fate.
In the ventral midbrain, precise spa-
tial and temporal transcription factor
expression is critical for proper develop-
ment (Sanders et al., 2002; Kele et al.,
2006; Prakash and Wurst, 2006). Our
studies on E12.5 and E14.5 ventral
midbrains suggested that PITX2 may
be downregulated in the red nucleus
during development (Figs. 5M–U, 8A–
C). To test this, we characterized mid-
brain Pitx2 expression at both the pro-
tein and mRNA levels using Cre line-
age tracing, in situ hybridization, and
immunofluorescence in Pitx2Cre/þ;NL
midbrains. From E14.5 through E18.5,
PITX2-lineage bGAL-positive neurons
were abundant in the superior collicu-
lus and sparse in the red nucleus (Fig.
9A,E,I). Pitx2 mRNA expression was
maintained in the superior colliculus,
red nucleus, and ventromedial popula-
tions through E18.5 (Fig. 9C,G,K and
data not shown). However, very few red
nucleus neurons were labeled with
PITX2 antibody at E14.5 and by E16.5
the red nucleus was devoid of PITX2-
positive neurons (Fig. 9D,H,L).
Previous studies showed that Pitx2
mRNA is auto-regulated (Briata et al.,
2003), which may partially explain the
discrepancy in red nucleus Pitx2
mRNA and protein. It is also possible
that translation or splicing of Pitx2 in
this region is uniquely regulated in red
nucleus neurons. Consistent with these
data, some pituitary cell lines appear to
regulate Pitx2 at the translational level
(Tremblay et al., 1998). In order to
determine whether the low number of
bGAL-positive PITX2-lineage neurons
in the red nucleus was due to low LacZ
reporter expression, we also crossed
Pitx2Cre/þ mice with ZsGreen mice,
which express the green fluorescent
molecule ZsGreen (ZsGrn) upon Cre
recombination (Madisen et al., 2009).
Midbrains of E14.5 Pitx2Cre/þ;ZsGrn
embryos displayed few ZsGrn-positive
Fig. 7. Early ventral midbrain patterning is PITX2-independent. E12.5 coronal sections were proc-
essed for immunofluorescence with antibodies against BRN3A (green) and FOXA2, LHX1/5, NKX6.1,
ISL1, or NKX6.2 (red) and imaged with confocal microscopy. A,B: FOXA2-positive cells in m6 are local-
ized in the ventricular zone and the BRN3A-positive red nucleus in both Pitx2Cre/þ and Pitx2Cre/ mid-
brains. C,D: LHX1/5-positive cells are distributed from deep m6 to the red nucleus, where all LHX1/5-
positive cells are also BRN3A-positive. LHX1/5 patterning appears unchanged in Pitx2Cre/ midbrains.
E,F: Cells in the ventricular zone are weakly NKX6.1-positive and a second, more lateral population is
strongly NKX6.1-positive. Neither NKX6.1-positive population displays co-localization with BRN3A and
both are unchanged in the Pitx2Cre/ midbrain. G,H: In both Pitx2Cre/þ and Pitx2Cre/ tissues, ISL1
marks cells in the oculomotor nucleus, which is surrounded by BRN3A-positive cells. I–J0: NKX6.2-pos-
itive cells intermingle with BRN3A-positive cells and a few cells are also BRN3A-positive (white arrows)
in both Pitx2Cre/þ and Pitx2Cre/ embryos. Scale bar in A ¼ 100 mm and applies to A–J. VZ, ventricular
zone; VM, ventromedial population; RN, red nucleus.
Fig. 8. PITX2-lineage neurons are glutamatergic and sparse in the red nucleus. A–F: Coronal
sections of E14.5 midbrains processed for PITX2 and BRN3A (A–C) or GABA (D–F) immunofluo-
rescence. Dotted areas demarcate cells in the PITX2-positive deep ventromedial population and
the red nucleus. Boxes in C, F, I, and L are enlarged in C0, F0, I0, and L0. A–C0: At E14.5, the red
nucleus is composed of BRN3A-positive neurons, a few of which are PITX2-positive. White
arrows indicate co-localization of BRN3A and PITX2, whereas open arrows indicate BRN3A-pos-
itive, PITX2-negative neurons. D–F0: Ventral GABAergic neurons are generally restricted to the
m5 domain, and are PITX2-negative. G–L0: E18.5 Pitx2Cre/þ;NL coronal sections were processed
for immunofluorescence for b-galactosidase (bGAL) and VGLUT2 or BRN3A and visualized with
confocal microscopy. G–I0: At E18.5, PITX2-lineage neurons are present in the red nucleus and
are VGLUT2-positive. J–L0: E18.5 red nucleus PITX2-lineage neurons are also BRN3A-positive.
White arrows indicate co-localization of bGAL and BRN3A, whereas the open arrow indicates
BRN3A-positive, bGAL-negative neurons. Dotted areas delimit the boundary of the red nucleus.
Scale bars in A and G ¼ 100 and 50 mm and apply to A–F and G–L, respectively. VM, ventrome-
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cells in the ventromedial population
and red nucleus (Fig. 9M,N), even
though neighboring sections showed
significant Pitx2 mRNA expression in
both populations (Fig. 9O,P). At E12.5,
many PITX2-positive cells in the red
nucleus can be identified by immuno-
fluorescence (Fig. 5), whereas very few
red nucleus neurons are bGAL-positive
by lineage tracing in Pitx2Cre/þ;NL
embryos (data not shown). Since differ-
ent Cre reporter systems (NL and
ZsGrn) showed low Pitx2Cre activity in
the E14.5 ventral midbrain, we specu-
late that Cre expression is regulated
between E12.5 and E14.5 in the red nu-
cleus at the transcriptional or transla-
tional level.
DISCUSSION
Through use of co-expression studies
and Cre lineage tracing, we have
identified GABAergic PITX2-positive
cells in the SGI, an intermediate layer
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glutamatergic PITX2-positive cells in
the ventral midbrain. Additionally,
we characterized the expression of
dorsal and ventral midbrain tran-
scription factors in reference to tem-
poral and spatial Pitx2 expression
and determined a role for PITX2 in
dorsal midbrain GABAergic differen-
tiation. We also discovered that
PITX2 protein is transient during de-
velopment of the red nucleus.
Studies on the developing midbrain
have begun to map transcription factor
expression by dorso-ventral domain
(Nakatani et al., 2007; Kala et al.,
2009). Our data on Pitx2 expression in
relation to other transcription factors
can now be incorporated into these
maps to produce a detailed summary of
transcription factors during midbrain
development (Fig. 10). We identified
PITX2-positive cells in all seven mid-
brain domains, with strongest expres-
sion in the m1–m4 and m6 domains
(Fig. 10A,B). In the m1–m2 domains,
Pitx2 is co-expressed with Lhx1/5 and
GABA (Fig. 10B) and marks unique
subpopulations of GABAergic neurons.
This is consistent with previous studies
showing distinct transcription factor
requirements for Ascl1 and Gata2 in
midbrain GABAergic differentiation
(Peltopuro et al., 2010). The m6 mid-
brain PITX2-positive neurons can be
divided into distinct regions: a ventro-
medial population and the red nucleus
(Fig. 10C,D). In the m6 domain, Pitx2
is co-expressed with Lhx1/5, Brn3a,
Foxa2, Nkx6.2, and Vglut2 (Fig.
10B,D). Interestingly, ventromedial
and red nucleus PITX2-positive popula-
tions both express Foxa2, Lhx1/5, and
Brn3a, whereas ventromedial PITX2-
positive neurons also express Nkx6.2.
This map suggests that Pitx2 marks
distinctive midbrain subpopulations







Our studies suggest that superior colli-
culus layers in the mouse can be iden-
tified based on transcription factor
expression. We also demonstrated that
PITX2 marks the intermediate layer
(SGI) of the superior colliculus and pre-
vious studies showed that superficial
and intermediate layers can be identi-
fied by expression of Pax7 and Brn3a
(Fedtsova et al., 2008). Our studies sug-
gest BRN3A marks the SO/SGI and
SAI, consistent with previous studies
on collicular glutamatergic localization
(Mooney et al., 1990). We showed that
PITX2 and BRN3A-positive popula-
tions occupy separate layers. Addition-
ally, previous studies showed that both
the SGI and the SGP can be identified
by expression of the Forkhead-5
(Foxb1) transcription factor (Alvarez-
Bolado et al., 1999). Thus, developing
superior colliculus layers can be identi-
fied by unique combinations of tran-
scription factor expression.
We have also shown that Pitx2 is
expressed upstream of and is necessary
for GABAergic differentiation in
PITX2-positive superior colliculus cells.
Our results are consistent with previ-
ous studies showing PITX2 is down-
stream of the GABAergic differentia-
tion factor GATA2 (Kala et al., 2009).
This positions PITX2 late in a cascade
of transcription factors necessary for
GABAergic differentiation. The earliest
fate-choice factors, Ascl1 and Helt,
promote GABAergic differentiation
(Miyoshi et al., 2004; Kala et al., 2009).
In turn, Helt is necessary for the
expression of Gata2, which is required
for both Lhx1/5 and Pitx2 expression.
In the ventral midbrain, we identi-
fied Pitx2 expression in a ventrome-
dial population and in the red nu-
cleus. Ventral midbrain populations
form arcs, each of which expresses a
specific combination of transcription
factors necessary for nucleogenesis.
Arc formation requires Sonic Hedge-
hog (Shh) signaling from the noto-
chord and loss of Shh signaling
results in disruption of arc structure
and patterning (Bayly et al., 2007).
Shh signaling contributes to the
entire ventral midbrain and is
required for repression of the dorsali-
zation factors Pax7, En2, and Fgf8
(Nomura and Fujisawa, 2000; Wata-
nabe and Nakamura, 2000). SHH is
also responsible for inducing Foxa2
expression, which regulates Nkx fam-
ily members and ventral midbrain
specification (Perez-Balaguer et al.,
2009). In addition to general ventral
midbrain determination, studies in
other tissues have shown that SHH
indirectly regulates Pitx2 expression
(Logan et al., 1998; Ryan et al., 1998),
further suggesting a requirement for
Fig. 9. Pitx2 expression is transient in the ventral midbrain. A–L: Adjacent coronal sections of
Pitx2Cre/þ;NL midbrains processed for bGAL histochemistry (A, B, E, F, I, J), Pitx2 mRNA (C, G, K),
or PITX2 immunofluorescence (D, H, L). The dotted line demarcates the red nucleus. A: At E14.5,
Pitx2-lineage neurons are located in the superior colliculus (SC) and red nucleus (RN). B: High mag-
nification of A shows only a few Pitx2-lineage cells in the red nucleus, despite high red nucleus
Pitx2 mRNA (C). D: Immunofluorescence indicates only a few PITX2-positive red nucleus cells. E, F,
I, J: At E16.5–E18.5, b-galactosidase activity shows Pitx2-lineage neurons in the superior colliculus
and red nucleus. G, H, K, L: The E16.5–E18.5 red nucleus continues to express Pitx2 mRNA,
although PITX2 protein is absent. M: Coronal section of an E14.5 Pitx2Cre/þ;ZsGrn midbrain showing
ZsGrn fluorescence in the superior colliculus. N: Few cells are fluorescent in the ventral midbrain as
seen in a high-magnification image of the red nucleus. O: A neighboring section to M processed for
Pitx2 in situ hybridization shows Pitx2 mRNA in the superior colliculus, ventromedial population, and
red nucleus. P: Higher magnification of the red nucleus in O. Dotted areas denote the ventromedial
population and red nucleus. Scale bar in A ¼ 125 mm and applies to A, E, and I; in B ¼ 32 mm and
applies to B–D, F–H, and J–L; in M and N ¼ 100 and 50 mm and applies to M,O and N,P,
respectively.
Fig. 10. Summary of Pitx2 expression in the developing dorsal and ventral midbrain. Sche-
matic is based on previously published models (Nakatani et al., 2007; Kala et al., 2009), wherein
early developmental transcription factors were mapped by domain. A,C: Cartoons of typical
E12.5 coronal sections showing PITX2-positive cells mapped onto the domain-delineated mid-
brain. PITX2-positive cells (red) are abundant in m1–m4 domains in the superior colliculus (SC)
and in the m6 domain (C) containing a ventromedial (VM) population and the red nucleus (RN).
PITX2-positive cells are sparse in m5 and m7. B,D: Solid bars show areas with no overlap in
marker expression with PITX2; hatched bars show areas of co-localization with PITX2. In m1–
m4, PITX2-positive neurons express some markers of GABAergic precursors and neurons
(LHX1/5 and GABA, respectively). In m6, PITX2 co-localizes with glutamatergic markers (D).
PITX2 is co-localized with the m6 precursor markers FOXA2, LHX1/5, BRN3A, and NKX6.2 in
the ventromedial population. PITX2 neurons in the early red nucleus are positive for FOXA2,
LHX1/5, and BRN3A, and red nucleus PITX2-lineage neurons are glutamatergic. DA, dopaminer-
gic neurons; GLUT, glutamatergic neurons; GABA, GABAergic neurons; VZ, ventricular zone;
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We characterized dorsal PITX2-posi-
tive neurons as GABAergic, consistent
with previous studies (Martin et al.,
2004), and ventral PITX2-positive neu-
rons as glutamatergic. Studies in the
spinal cord have identified PITX2-posi-
tive neurons as cholinergic and gluta-
matergic interneurons that are respon-
sible for modulating the frequency of
motor neuron firing (Zagoraiou et al.,
2009). Together, these observations
suggest that PITX2 may regulate neu-
rotransmitter choice based on rostral-
caudal positioning. This reliance on
regional or axial-level factors for mid-
brain development is consistent with
earlier studies showing that dorsal and
ventral midbrain neurons are derived
from different progenitor pools (Tan
et al., 2002) and respond to distinct de-
velopmental signals.
In conclusion, we report that Pitx2 is
expressed in GABAergic neurons occu-
pying the SGI and that PITX2 is neces-
sary for their GABAergic differentia-
tion and migration, but not early
patterning. In contrast, most ventral
Pitx2-lineage neurons are glutamater-
gic and are located in ventromedial and
red nucleus populations. Additionally,
each PITX2-positive population ap-
pears to be characterized by a unique
combination of transcription factors,
suggesting locally regulated mecha-
nisms are important for glutamatergic
and GABAergic differentiation. Fur-
ther research into the developmental
requirements of these neuronal subpo-
pulations may facilitate diagnosis and
insights into mechanisms of diseases/





Wild type mice were on a C57BL/6J
background (JAX 000664). Pitx2Cre/þ
mice (Liu et al., 2002) were crossed
with FlpeR mice (JAX 003946) to excise
the neomycin cassette. Pitx2Cre/þ;NL
and Pitx2Cre/;NL embryos were gen-
erated as previously described (Skid-
more et al., 2008). ZsGrn reporter
mice were obtained from Jackson
Laboratories (Bar Harbor, ME) and
are on a C57BL/6J background (JAX




Timed pregnancies were established
with the morning of plug identifica-
tion designated as E0.5. Pregnant
dams were euthanized using cervical
dislocation. Embryos were fixed in 4%
paraformaldehyde for 30 min to 2 hr
depending on age and genotype.
Embryos for cryosectioning were cryo-
protected in 30% sucrose-PBS over-
night and frozen in O.C.T. embedding
medium (Tissue Tek, Torrance, CA),
and sectioned at 12 mm. Paraffin-em-
bedded embryos were sectioned at a
thickness of 7 mm. From each embryo
and pup, an amniotic sac or tail was
retained for genotyping. All proce-
dures were approved by the Univer-
sity Committee on Use and Care for




To collect embryonic tissue for X-Gal
staining, Pitx2Cre/þ females were
crossed with Pitx2þ/þ;NL males.
Pregnant dams were anesthetized
with 250 mg/kg body weight tribro-
moethanol and perfusion fixed with
4% paraformaldehyde (Fisher, Wal-
tham, MA). E14.5 whole embryos and
E16.5–E18.5 brains were isolated and
further fixed in 4% paraformaldehyde
at 4C for 20 min to 3 hr. P8 pups
were anesthetized as described above
and perfusion fixed. Brains were
removed and fixed at 4C for 3 hr in
4% paraformaldehyde. Samples were
washed with PBS, cryoprotected in
30% sucrose-PBS overnight, and fro-
zen in O.C.T. embedding medium
(Tissue Tek, Torrance, CA) for cryo-
sectioning. Frozen sections all were
postfixed with 0.5% glutaraldehyde
fixative, washed in X-Gal Wash Buffer,
and stained with X-Gal Staining Solu-
tion overnight at 37C as previously
described (Sclafani et al., 2006). Slides
were washed in PBS and X-Gal Wash
Buffer, eosin counterstained, and
mounted with Permount (Fisher).
Acetylcholinesterase (AChE)
Staining of Frozen Sections
To collect postnatal tissue for AChE
staining, wild type P8 tissue was pre-
pared and frozen as described above.
Sections were post-fixed in 4% para-
formaldehyde and incubated in 0.1%
H2O2. AChE staining was performed




Immunofluorescence on frozen and
paraffin-embedded tissue was per-
formed as described (Martin et al.,
2002, 2004) with rabbit anti-PITX2 at
1:8,000 (Zagoraiou et al., 2009), rabbit
anti-PITX2 at 1:4,000 (Capra Science,
Ångelholm, Sweden), guinea pig anti-
BRN3A at 1:400 (Fedtsova and
Turner, 1995), rabbit-anti VGLUT2 at
1:1000 (Millipore, Billerica, MA), rab-
bit anti-GABA at 1:1,000 (Sigma, St.
Louis, MO), guinea pig anti-GATA2 at
1:500 (Peng et al., 2007), guinea pig
anti-NKX6.2 at 1:8000 (Vallstedt
et al., 2001), chicken anti-b-galactosi-
dase at 1:200 (Abcam, Cambridge,
MA) and the following mouse antibod-
ies from the Developmental Studies
Hybridoma Bank: anti-LHX1/5 (4F2)
at 1:100, anti-FOXA2 (4C7) at 1:100,
anti-ISLET1 (40.2D6) at 1:500, anti-
NKX2.2 (74.5A5) at 1:500, anti-PAX3
at 1:100, anti-PAX7 at 1:100, or anti-
NKX6.1 (F64A6B4) at 1:250. In situ
hybridization was performed as previ-
ously described (Martin et al., 2002,
2004) using a cRNA probe for Pitx2.
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